SyntiGenSyntiGen-primedKoch InstituteDFCIBridge grantB16F10-OVAPanc02 tumors
… which can be leveraged therapeutically. These findings support SyntiGen as a promising strategy for personalized and localized cancer i…
1articles mentioning drugs
9drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: SyntiGen ×
SyntiGen
This drug is selected. Its supporting articles are shown below.